R&G PharmaStudies301333 
$5.490.70%24h
0.70%24h
Global rank11079
Market cap$526.66M
Change 7d-2.53%
YTD Performance-39.66%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Category
Market capitalization of R&G PharmaStudies (301333)
As of September 2024, R&G PharmaStudies has a market cap of $526.66M. This makes R&G PharmaStudies the world's 11079th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of R&G PharmaStudies from 2022 to 2024
-
Value:-
Market cap history of R&G PharmaStudies from 2022 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $654.98M | -24.95% |
| 2023 | $872.76M | -21.69% |
| 2022 | $1.11B | - |
301333 Market Cap Today is $526.66M 0.70% - 19 Sept 2024
View largest stocks by market cap 
